Moore Capital Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-90,000
| Closed | -$23.3M | – | 399 |
|
|
2023
Q4 | $23.3M | Buy |
90,000
+30,000
| +50% | +$7.76M | 0.4% | 34 |
|
|
2023
Q3 | $15.4M | Buy |
+60,000
| New | +$15.4M | 0.29% | 52 |
|
|
2023
Q2 | – | Sell |
-1,500
| Closed | -$417K | – | 484 |
|
|
2023
Q1 | $417K | Buy |
+1,500
| New | +$417K | 0.01% | 302 |
|
|
2022
Q4 | – | Sell |
-17,995
| Closed | -$4.81M | – | 543 |
|
|
2022
Q3 | $4.81M | Sell |
17,995
-10,684
| -37% | -$2.85M | 0.11% | 188 |
|
|
2022
Q2 | $5.85M | Buy |
+28,679
| New | +$5.85M | 0.15% | 132 |
|
|
2021
Q4 | – | Sell |
-20,206
| Closed | -$5.72M | – | 735 |
|
|
2021
Q3 | $5.72M | Sell |
20,206
-58,952
| -74% | -$16.7M | 0.09% | 208 |
|
|
2021
Q2 | $27.4M | Buy |
+79,158
| New | +$27.4M | 0.39% | 46 |
|
|
2020
Q1 | – | Sell |
-9,924
| Closed | -$2.95M | – | 164 |
|
|
2019
Q4 | $2.95M | Buy |
+9,924
| New | +$2.95M | 0.1% | 162 |
|
|
2019
Q1 | – | Sell |
-33,792
| Closed | -$10.2M | – | 282 |
|
|
2018
Q4 | $10.2M | Buy |
+33,792
| New | +$10.2M | 0.4% | 43 |
|
|
2014
Q3 | – | Sell |
-32,500
| Closed | -$10.2M | – | 340 |
|
|
2014
Q2 | $10.2M | Buy |
+32,500
| New | +$10.2M | 0.25% | 73 |
|
|
2013
Q4 | – | Sell |
-10,000
| Closed | -$2.41M | – | 310 |
|
|
2013
Q3 | $2.41M | Buy |
10,000
+5,000
| +100% | +$1.2M | 0.05% | 170 |
|
|
2013
Q2 | $1.08M | Buy |
+5,000
| New | +$1.08M | 0.03% | 154 |
|